Download Program - Canadian Society of Transplantation

www.banfffoundation.org
BANFF-CSTJointScientificMeeting
October5–10,2015
Vancouver,BritishColumbia
www.cst-transplant.ca
MONDAY,OCTOBER5,2015
BANFF PRE-MEETING: PRECISION DIAGNOSTICS IN TRANSPLANTATION - MOLECULAR PATHOLOGY (MORNING SESSION)
GRAND BALLROOM AB + PASSAGE (MODERATORS: ALEXANDRE LOUPY, MICHAEL ME NGEL)
Start
End
Description
Alexandre Loupy, Michael Mengel
08:00
08:15
Introduction and Objective: Consensus in Molecular Transplant Diagnostics
Philip Halloran
08:15
08:45
Molecular Assessment and Landscape of ABMR in Kidney Transplants
Enver Akalin
08:45
09:15
Clinical and Molecular Significance of Microvascular Inflammation in Kidney Allografts
Jeff Reeve
09:15
09:45
Molecular Assessment of TCMR, Mixed Rejection & Borderline Lesions
Minnie Sarwal
09:45
10:15
A Cross Organ Common Immune Module for Graft Reejection
Coffee Break
Michael Mengel
10:30
11:00
Molecular Assessment of ABMR in Heart Transplants
Daniel Salomon
11:00
11:30
What’s New in Non-Invasive Biomarkers: Blood
Thangamani Muthukumar
11:30
12:00
What’s New in Non-Invasive Biomarkers: Urine
LUNCH SYMPOSIUM: ANTI-GRAFT ANTIBODIES IN TRANSPLANTATION: IMPROVING THE GOLD STANDARD, IMPLEMENTING
COMPLEMENTARY APPROACHES AND MOVING BEYOND HLA (LUNCH PROVIDED WITH SUPPORT FROM ONE LAMBDA. A
THERMOFISHER SCIENTIFIC BRAND.)
GRAND BALLROOM AB + PASSAGE (MODERATORS: CARMEN LEFAUCHER, ANAT TAMBUR)
Start
End
Description
Anat Tambur
12:00
12:30
What’s Hot - What’s New in HLA Science: Take Home Messages from the 2015 ASHI
Adriana Zeevi
12:30
01:00
An Overview of Laboratory Testing Methods in SOT: Value and Limitations
Peter Nickerson
01:00
01:30
The Future of HLA: Eplet Mismatch to Improve Transplant Candidates Risk Assessment
BANFF PRE-MEETING: PRECISION DIAGNOSTICS IN TRANSPLANTATION - MOLECULAR PATHOLOGY (AFTERNOON SESSION)
GRAND BALLROOM AB + PASSAGE (MODERATORS: ALEXANDRE LOUPY, MICHAEL ME NGEL)
Start
End
01:30
02:00
02:00
02:30
02:30
03:00
03:30
04:00
04:00
04:15
Description
Osmar Zaiane
Insights of Big Data Analyses in the 21st Century of Biomedical Research
Kim Solez
Bridge between Transplantation and Regenerative Medicine
Kim Solez for Doris Taylor
Building New Hearts. Regenerative Medicine Becomes a Reality
Coffee Break
Paul Keown
Next Generation Sequencing: Applications in Transplant Diagnostics
Parmjeet Randhawa
An example for Clinical Application - Next Generation Sequencing in Biopsies with
Polyomavirus BK Nephropathy: Patient - specific TCR b utilization patterns and presence of
unique T-cell clonotypes
TUESDAY,OCTOBER6,2015
CST BOARD MEETING
PORT HARDY
Start
End
Description
07:00
05:00
Closed Meeting
BANFF: SUMMARY OF PREMEETING, BANFF WORKING GROUPS RESULTS AND DIRECTIONS REGARDING BANFF
CLASSIFICATION AMENDMENTS (CO-SPONSORED BY RENAL PATHOLOGY SOCIETY)
GRAND BALLROOM AB + PASSAGE (MODERATORS: LORRAINE RACUSEN, KIM SOLEZ)
Start
End
Description
Kim Solez, Lorraine Racusen
08:00
08:15
Banff Meeting Intro
Kim Solez, Michael Mengel
08:15
08:30
Annual Report from the Banff Foundation
Michael Mengel
08:30
08:45
Summary of the Pre-Meeting
Parmjeet Randhawa
08:45
09:00
Borderline/TCMR Working Group Update
Lynn Cornell
09:00
09:15
Highly Sensitized Working Group Update
Banu Sis
09:15
09:30
Molecular Group Update
Volker Nickeleit
09:30
09:45
BKv Group Update
Helen Liapis
09:45
10:00
Implantation Biopsy Working Group Final Report
Coffee Break
Mark Haas
10:30
10:45
The New Diagnostic Criteria for ABMR (Banff 2013): Remarks, Difficulties, Amendments?
Banu Sis
10:45
11:00
What Criteria Should Apply to Isolated V Lesions and How To Update the Classification?
Volker Nickeleit
11:00
11:15
Prospects for Modifying/Improving the Banff Criteria for Borderline and TCMR
M. Haas, B Sis, B Colvin
11:15
11:45
Group Discussion
LUNCH SYMPOSIUM: MTORI IN SOLID ORGAN TRANSPLANTATION: NEW UNDERSTANDINGS, NEW DIRECTIONS AND
ADVANCES (LUNCH PROVIDED WITH SUPPORT FROM NOVARTIS)
GRAND BALLROOM AB + PASSAGE(MODERATORS: ALEXANDRE LOUPY, CHRISTOPHE LEGENDRE)
Start
End
Description
Federico Oppenheimer
12:00
12:20
Clinical Relevance of New Strategies Using Combined mTORi and Reduced CNI Regimens
in Kidney Transplants
Guillaume Canaud
12:20
12:40
mTORi for Preventing Antiphospholipid Syndrome Recurrence Post Kidney Transplantation
Luciano Potena
12:40
01:00
mTORi Based Strategies for Preventing Chronic Heart Allograft Vasculopathy
BANFF KIDNEY CONCURRENT I: ANTIBODIES AND INJURY TO GRAFT ENDOTHELIUM AND EPITHELIUM
GRAND BALLROOM AB + PASSAGE (MODERATORS: LYNN CORNELL, CANDICE ROUFOSSE)
Start
End
Description
Christopher Bellamy
01:00
01:30
Multiplex in situ phenotyping of macrophages in allograft biopsies
Roger Wiggins
01:30
02:00
Podocyte Injury After Transplantation: Novel Insights
1
Candice Roufosse
Significance of Double Contours and Peritubular capillary basement membrane multilayering
in renal allograft biopsies
Robert Colvin
02:30
03:00
The Pathology of Tolerance and ABMR: From Animal Model to Human Biopsies
Coffee Break
Elaine Reed
03:30
04:00
Anti-HLA Antibody Binding Trigger Endothelial Cell Signaling: Molecular Pathways and
Functional Consequences
Annette Jackson
04:00
04:30
Endothelial Cell Rreactive Antibodies: Novel Antigenic Targets Associated With
Microvascular Injury in Kidney Transplantation
Carmen Lefaucheur
04:30
05:00
Endothelium and Transplant Arteriosclerosis from Heart to Kidney: Epidemiologic
Demonstration
BANFF LIVER CONCURRENT I
GRAND BALLROOM D (MODERATORS: JACQUELINE O’LEARY, MAX SMITH)
Start
End
Description
Jake Demetris
01:00
01:30
Welcome & Session Goals
Luis G. Hidalgo
01:30
02:00
Eosinophils and NK cells in ADCC and Liver Injury
Christopher Bellamy
02:00
02:30
Macrophages in Liver Allografts
Delsey Neil
02:30
03:00
C4d TMA Concordance Study Results
Coffee Break
Geoff McCaughan
03:30
04:00
Liver Allograft Pathology After Effective Anti-HCV Therapies - Changes and Challenges
Arnaud Del Bello
04:00
04:30
De Novo DSA: Clinical and Histopathological Manifestations
BANFF LUNG CONCURRENT: CHRONIC LUNG ALLOGRAFT DYSFUNCTION
GULF ISLANDS BCD (MODERATORS: CAROL FARVER, DEAN W. WALLACE)
Start
End
Description
Jamie Todd
01:00
01:30
Clinical Features of Chronic Lung Allograft Dysfunction (CLAD)
David Hwang
01:30
02:00
Pathophysiology of CLAD/RAS (Restrictive Allograft Syndrome)
Elizabeth Pavlisko
02:00
02:30
Pathophysiology of CLAD/BOS (Bronchiolitis Obliterans Syndrome)
Rajan Saggar
02:30
03:00
Pathophysiology of CLAD/Chronic Vascular Changes
Coffee Break
Carol Farver
03:30
04:00
The Pathology of Antibody-Mediated Rejection in Pediatric Lung Transplantation
Nancy Reinsmoen
04:00
04:30
HLA and Non-HLA Donor Specific Antibodies and Clinical Outcomes in Lung TX
04:30
05:00
Group Discussion
02:00
02:30
CNTRP (POSITIVE STUDY (PROJECT 6) MEETING)
GRANVILLE
Start
End
12:30
05:00
Description
External Meeting
2
CST RESEARCH FITS: PLANNING A CAREER IN ACADEMIC TRANSPLANT PROGRAMS
ORCA (MODERATOR: JEFFREY SCHIFF)
Start
End
Description
Jeffrey Schiff
01:00
01:10
Opening Remarks
Alp Sener
01:10
01:40
Starting a Basic Science Research Program
Christine Ribic
01:40
02:10
Starting a Clinical Science Research Program
Jeffrey Schiff
02:10
02:40
Creating a Teaching Dossier
A. Sener, C. Ribic, J, Schiff
02:40
03:00
Panel Discussion
Coffee Break
03:30
03:55
Breakout Session #1 with Transplant Program Directors
03:55
04:20
Breakout Session #2 with Transplant Program Directors
04:20
04:50
Panel Session with Program Directors
Jeffrey Schiff
04:50
05:00
Closing Remarks
PROBE MEETING
GALIANO
Start
End
Description
04:00
05:30
External Meeting
SPONSOR COCKTAIL RECEPTION
CONSTELLATION SUITE
Start
End
Description
05:00
06:00
By Invitation only
CANADIAN PEDIATRIC GROUP BUSINESS MEETING & SESSION
FINBACK (MODERATORS: AVIVA GOLDBERG, SEEMA MITAL)
Start
End
Description
Aviva Goldberg
06:00
06:30
Welcome and Introductions
Brendan Keating
06:30
07:00
Discovering Genomic Underpinnings of Rejection and Complications in Transplantation
Chia Wei Teoh
07:00
07:15
Trainee Abstract Award Presentation
07:15
07:30
Updates on Research Initiatives, New Collaborative Research
07:30
08:00
Business Meeting (Members only)
EXHIBIT HALL
GRAND BALLROOM CD
Start
End
Description
06:00
11:45
Exhibitor Setup
3
WEDNESDAY,OCTOBER7,2015
JOINT AST-BANFF-CST SYMPOSIUM
GRAND BALLROOM AB + PASSAGE (MODERATORS: JIM ALLAN, STEVEN PARASKEVAS, KIM SOLEZ)
Start
End
Description
Rob Fairchild
07:00
07:20
Tests of T Cell Reactivity
Kathryn Tinckam
07:20
07:40
Failure to Adopt: Screening for Donor Specific Antibodies
Robert Colvin
07:40
08:00
Mixing mRNA and microscopes: The Biopsy with and without molecular diagnostics
Roslyn Mannon
08:00
08:20
Is the Problem Failure to Demonstrate the Added Value of the Test(s) or a Lack of
Therapeutics?
POSTER SETUP
GRAND BALLROOM CD
Start
End
Description
07:00
09:30
Wednesday Poster Boards – Poster Setup
JOINT PLENARY SESSION #1: FUTURE DIRECTIONS OF TRANSPLANTATION: EXPANDING THE DONOR POOL AND
IMPLEMENTING NEW TECHNOLOGIES
GRAND BALLROOM AB + PASSAGE (MODERATORS: JOSEPH KIM, GREG KNOLL)
Start
End
Description
Steven Paraskevas, Kim Solez
08:30
08:40
Presidents’ Opening Remarks
John Gill
08:40
09:05
Extending the donor pool: New registries, allocation, and policies: North American
perspectives
Christian Jacquelinet
09:05
09:25
Extending the donor pool: New registries, allocation, and policies: European perspectives
Coffee Break among Posters
Darren Freed
10:00
10:25
Extending the Donor Pool II: Preservation Across Different Organs (Pulsatile Perfusion
Devices)
Julie Ho
10:25
10:50
Implementing Omics into Daily Practice: Taking the Road and the Lessons from Nephrology
PRESIDENTS’ MEETING
GULF ISLANDS BCD
Start
End
Description
09:00
10:30
External Meeting
LEADING CLINICAL PRACTICES COMMITTEE MEETING
GULF ISLANDS BCD
Start
End
Description
11:00
12:00
External Meeting
JOINT ORAL ABSTRACT PRESENTATIONS - SESSION I
GRAND BALLROOM AB + PASSAGE (MODERATORS: PROSANTO CHAUDHURY, ALEXANDRE LOUPY)
Start
End
Description
Marion Rabant
11:00
11:10
Heterogeneity of isolated v lesions in kidney transplantation
Darren Freed
11:10
11:20
Ex vivo perfusion in a loaded state improves the preservation of donor heart function
Sacha De Serres
11:20
11:30
Critical Apparaisal of the New Banff Criteria for Chronic Antibody-Mediated Rejection in the
Real Life Setting
2
Qianni Hu
Mitochondrial Damage-Associated Molecular Patterns (MTDs) released from hepatic
ischemia reperfusion induce inflammatory response
Alexandre HERTIG
11:40
11:50
Markers of Endothlial-to-mesenchymal transition: evidence for Antibody-Endothelium
interaction during antibody-mediated rejection
Anand Ghanekar
11:50
12:00
Differentiation of Functional Cholangiocytes from Human Pluripotent Stem Cells for the
Modeling of Biliary Disease
LUNCH SYMPOSIUM: COMPLEMENT-MEDIATED DISEASES IN RENAL TRANSPLANTS AND THEIR LINK TO ABMR (LUNCH
PROVIDED WITH SUPPORT FROM ALEXION PHARMACEUTICALS)
GRAND BALLROOM AB + PASSAGE (MODERATORS: KATHRYN TINCKAM)
Start
End
Description
Christophe Legendre
12:00
12:20
Targeting Complement in Recurrent Atypical Haemolytic Uraemic Syndrome
John Gill
12:20
12:40
The Role of Complement and Complement Inhibition in Recurring Glomerulonephritis
Steven Sacks
12:40
01:00
Targeting Complement for Preventing Delay Graft Function
CANADIAN KIDNEY TRANSPLANT WORKING GROUP BUSINESS MEETING
GALIANO
Start
End
Description
01:00
05:30
Closed Meeting (Members only)
CANADIAN LIVER TRANSPLANT NETWORK (CLTN) BUSINESS MEETING
GALIANO
Start
End
Description
01:00
05:30
Closed Meeting (Members only)
BANFF LIVER CONCURRENT II
FINBACK (MODERATORS: CHRISTOPHER BELLAMY, STEFAN HUBSCHER)
Start
End
Description
Stefan Hubscher
01:00
01:30
Pathophysiologic Mechanisms of Liver Allograft Injury/Fibrosis
Sandy Feng
01:30
02:00
Long-Term Follow-up and Weaning Immunosuppression in Pediatric Recipients: Factors
Influencing the Graft
Jacqueline O'Leary
02:00
02:30
Chronic Antibody-Mediated Rejection: Perspectives and Issues
Coffee Break among Posters
03:30
05:00
Group Discussion
BANFF PANCREAS CONCURRENT I: UPDATE ON PANCREAS ALLOGRAFT PATHOLOGY ISSUES / II: ACCURATE
DETERMINATION OF THE CAUSE OF GRAFT LOSS IN WHOLE PANCREAS TRANSPLANTS
ORCA (MODERATORS: CINTHIA DRACHENBERG, JON ODORIC)
Start
End
Description
Danniele Holanda
01:00
01:25
Utility of Duodenal Cuff Biopsies for Diagnosis of Pancreas Rejection
Erik Larsson
01:25
01:50
CMV Infection of the Duodenal Cuff in Whole Pancreas Allografts
Megan Troxell
01:50
02:15
Pale Acinar Nodules and Other Peculiar Histological Findings in Pancreas Allografts
Hanneke de Kort
02:15
02:40
Clinical and Diagnostic Issues Regarding Vascular Lesions in Pancreas Allografts
María Toniolo
02:40
03:00
Clinical Impact of Performing Concurrent Pancreas-Kidney Allograft Biopsies
Coffee Break among Posters
11:30
11:40
3
John Papadimitriou
Morphological Spectrum of Lesions Associated with Graft Failure in Pancreas Transplants
David Klassen
03:55
04:20
Graft Failure in Whole Pancreas and Islet Transplants: UNOS Perspective
Rainer Gruessner
04:20
04:45
Clinical Aspects of Pancreas/Islet Failure
Steven Paraskevas
04:45
05:10
Clinicopathological Algorithm for the Accurate Etiological Diagnosis of Graft Failure in
Pancreas Transplants
05:10
05:30
Closing Comments, Future Plans, Group Discussion
BANFF HEART CONCURRENT I & II: IMPROVING HEART TRANSPLANT REJECTION DIAGNOSTIC SYSTEM: UNMET NEEDS,
CURRENT LIMITATIONS, NEW IMPLEMENTATIONS AND FUTURE DIRECTIONS
PAVILLION BALLROOM C (MODERATORS I: GERALD BERRY, LORI WEST; MODERATORS II: REX NEAL SMITH)
Start
End
Description
Patrick Bruneval
01:30
01:50
The Pathological Classification of Antibody-Mediated Rejection: Certainties, Uncertainties
and Prospects for its Improvement
Adriana Zeevi
01:50
02:10
DSA in Thoracic Transplant: Where Do We Stand?
Annalisa Angelini
02:10
02:35
Microcirculation Injury in Acute and Chronic Heart Rejection
Elaine Reed
02:35
03:00
Endothelial Cell in Cardiac AMR: Interplay Between Antibodies, Complement, and
Leukocytes
Coffee Break among Posters
Dylan Miller
03:30
04:00
Modern Pathology of CAV in the Era of AMR
Thomas Thum
04:00
04:30
MicroRNAs and Small Non-Coding RNA’s in Heart Transplantation: Tissue and Sera
Scott Tebbutt
04:30
05:00
Leukocyte Transcripts as Biomarkers in Cardiac Transplantation
05:00
05:30
Group Discussion
ALLIED HEALTH GROUP SESSION & BUSINESS MEETING
PAVILLION BALLROOM D
Start
End
Description
Janet Madill
01:30
01:45
Welcome and Introductions
Sean Spina
01:45
02:30
Technology in Clinical Practice. How the Digital Revolution is Affecting Patient Care.
Nancy Howes
02:30
03:00
The TONE Program: The Transplant ONline Exercise Program. How Physiotherapists Can
Use Technology to Promote Preoperative Exercise
Coffee Break among Posters
Daniel Buchman
03:30
04:10
The Illusion of Privacy
Tania Janaudis-Ferreira
04:10
04:17
Physical Activity Participation in Solid Organ Transplant Recipients: What are the Barriers
and Facilitators?
Natalia Liapounova
04:18
04:25
Pediatric pre-transplant cognitive function, behavior problems and lung allocation system
(LAS) scores.
Holly Mansell
04:26
04:33
A qualitative analysis of pre-transplant educational needs from the post-transplant
perspective
03:30
03:55
4
Tania Janaudis-Ferreira
Changes in functional outcomes after an inpatient rehabilitation program for solid organ
transplant recipients
04:45
05:20
Allied Health Business Meeting (Members only)
05:20
06:30
Networking Session with CANRESTORE
CANADIAN DONATION GROUP BUSINESS MEETING
PAVILLION BALLROOM AB
Start
End
Description
01:30
03:30
Closed Meeting (Members only)
POSTER DISMANTLE
GRAND BALLROOM CD
Start
End
Description
04:34
04:41
07:00
07:30
Wednesday Poster Boards – Poster Dismantle
OKTOBERFEST SOCIAL
VANCOUVER ART GALLERY ROOFTOP
Start
End
Description
07:30
11:00
Ticketed social event
5
JOINT POSTERS & EXHIBITS: AUTHOR PRESENTATIONS (WED 9:30AM)
GRAND BALLROOM CD
Alvita Chan
Impact of Social Determinants of Health on Liver Transplantation
Antoine Roux
DSA characteristics associated with antibody mediated rejection in Lung Transplantation.
Berna Yelken
The Effect of C1q Test Done Before Kidney Transplantation on Acute Rejections: Center Experience
Chee Loong Saw
Pattern of Pre- and Post-Transplant Anti-HLA Antibody Detection in Pediatric Renal Transplant Recipients
Isabelle Lapointe
Eplet Analysis Supports Easier Identification and Exclusion of Allele Specific HLA Antibodies
Joseph Kim
Early Hospital Readmissions Following Kidney Transplantation: A Systematic Review
Luis G. Hidalgo
A CASE OF HEART VALVE REPLACEMENT LEADING TO EXTENSIVE SENSITIZATION - AN EXAMPLE OF
THE WORST HLA CLASS II TYPING FOR A TRANSPLANT RECIPIENT
Maria Picken
Adenovirus Infection in Kidney Transplant Recipients
María Toniolo
Simultaneous pancreas-kidney transplant: Histologic evaluation
Ngan Lam
Validation of Kidney Transplantation Using Administrative Data
Nicholas Dawson
DESIGN AND OPTIMIZATION OF MASS CYTOMETRY TO MEASURE IMMUNE RECONSTITUTION POSTHEMATOPOEITC STEM CELL TRANSPLANT
Patrick Luke
WARM BLOOD-BASED REPERFUSION WITH CORM-401 REDUCES ISCHEMIA REPERFUSION INJURI (IRI)
IN AN EX-VIVO PORCINE MODEL OF THE DONATION AFTER CIRCULATORY DEATH KIDNEY DONOR
Renata Ponsirenas
Enhancing positive predictive values for antibody mediated rejection through improved antibody characterization
RK Sharma
Donor Specific Antibodies (DSA) in living related transplantation
Sait Sen
EVALUATION OF PATIENTS WITH ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
Tomokazu Shimizu
Subclinical tacrolimus nephrotoxicity in protocol biopsies obtained more than 5 years after renal allograft
transplantation
Trana Hussaini
Investigating the Association between Hypomagnesaemia and Calcineurin Inhibitor Induced Nephrotoxicity in Liver
Transplant Recipients: A Case-Control Study
Yasemin Ozluk
The efficacy of immunoadsorbtion in the treatment of late antibody mediated rejection
6
JOINT POSTERS & EXHIBITS: AUTHOR PRESENTATIONS (WED 3PM)
GRAND BALLROOM CD
Andre Teixeira
THE ROLE OF POSTREPERFUSION BIOPSIES IN LIVER TRANSPLANTATION; CORRELATION BETWEEN
CLINICAL, LABORATORIAL AND HISTOPATHOLOGICAL FINDINGS
Bahman Afzali
From ultrastructure to molecular testing: Assessment of antibody-mediated tissue injury in human cardiac allograft
biopsies
Berna Yelken
Protocol biopsy is very important for kidney graft survival in desensitize patients
Heather Stevenson
Isolated obliterative arteriopathy in liver allografts should prompt evaluation for underlying chronic antibodymediated rejection
Johann Moritz Kaths
Normothermic Ex Vivo Kidney Perfusion Represents a Novel Preservation Method for Heart Beating Donor Kidney
Grafts
Marie-Chantal Fortin
Donors’ and recipients’ views on altruistic unbalanced paired kidney exchange
Maryam Demian
Higher Self Efficacy and Simplification of Dosing Regimen are Predictive of Better Medication Adherence in Adult
Renal Transplant Recipients
Maud Racape
A NEW DIAGNOSTIC SCORE FOR MICROVASCULAR INFLAMMATION IN ANTIBODY MEDIATED
REJECTION IN HEART TRANSPLANTATION
Medhat Askar
Comparison Between IgG and IgM De Novo Donor Specific HLA Antibody (dnDSA) Characteristics Among
Patients with Symptomatic and Asymptomatic Antibody Mediated Rejection in Heart Transplant Recipients
Olusegun Famure
THE LONG-TERM CARE OF KIDNEY TRANSPLANT RECIPIENTS: WHAT IS THE ROLE OF THE GENERAL
NEPHROLOGIST
Oyedele Adeyi
Active Sinusoidal Infiltrate and EBV Infection in Post-Liver Transplant Biopsies
RK Sharma
Loss of suppressive function of CD4+CD25+FOXP3+ T regulatory cells in renal patients with chronic allograft
dysfunction in late post transplant period
Shirin Aladwan
ADVERSE SYMPTOMS OF IMMUNOSUPPRESSANTS: PILOT SURVEY OF SOLID ORGAN TRANSPLANT
RECIPIENTS
Tahani Alamodi
KIDNEY TRANSPLANTATION IN A PEDIATRIC PATIENT WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME
AND A NOVEL C3 GENE VARIANT
Theone Paterson
Personality factors positively predict medication adherence as measured via self-report and tacrolimus blood level
post-assessment.
Vanessa Michaud
Transition from pediatric to adult healthcare: Evaluation of the medical and psychosocial outcomes of a Young
Adult Clinic for renal transplant recipients.
Yasemin Ozluk
The link between recurrent glomerular diseases and allograft rejection: Under immunosuppression
7
JOINT POSTERS & EXHIBITS: AUTHOR PRESENTATIONS (WED 6PM)
GRAND BALLROOM CD
Alison Gareau
Serum proteins are significantly upregulated in patients with clinical antibody-mediated rejection
Asami Takeda
Pathological diagnosis of subclinical chronic antibody-mediated rejection in kidney allografts with de novo positive
donor-specific antibodies – usefulness of C4d positivity in glomerular capillaries
Berna Yelken
The impact of repeated allograft biopsies on indication of Eculizumab rescue treatment in patients with serious
antibody mediated rejection
Bing Yang
PRE-EXISTING ANTI-LG3 ANTIBODIES AGGRAVATE RENAL ISCHEMIA-REPERFUSION INJURY AND
CORRELATE WITH AN INCREASED RISK OF DELAYED GRAFT FUNCTION
Boris Gala-Lopez
Anti-aging Glycopeptide Protects Human Islets Against Tacrolimus-related Injury and Facilitates Engraftment
Daisuke Toki
Interstitial Fibrosis is the Critical Determinant of Impaired Renal Function in Transplant Glomerulopathy
Esme Dijke
Enhanced suppressive capacity of regulatory T cells (Tregs) expanded from human thymus in the presence of
rapamycin.
Istvan Mucsi
Ethnicity as a potential barrier to pre-transplant evaluation completion in a Canadian setting
James Lan
Unambiguous HLA Genotyping using Long-Range PCR and Next-Generation Sequencing (NGS) on BuccalExtracted DNA: Results from 4,000 Donor Recruitment Samples
Joseph Kim
Vitamin D Levels and Post-Transplant Diabetes Mellitus After Kidney Transplantation
Kasia Sablik
IVIG AND HIGH DOSE STEROID TREATMENT OF TRANSPLANT GLOMERULAPATHY EFFECTIVELY
SLOWS PROGRESSION OF LOSS OF RENAL ALLOGRAFT FUNCTION
Minal Borkar
BK polyomavirus orchestrates renal fibrosis through epigenetic modulations and induces necroptosis in renal
tubular cells
Patrick Luke
IMMUNOSUPPRESSIVE ACTIONS OF CARBON MONOXIDE RELEASING MOLECULE (CORM-401) ON TOLLLIKE RECEPTORS AND RENAL ISCHEMIA REPERFUSION INJURY
Rahul Chanchlani
Are Hypomagnesemia and Hypokalemia Novel Risk Factors for New-Onset Diabetes in Pediatric Solid Organ
Transplant Recipients
Renata Ponsirenas
Circulating anti-HLA IgG subclasses detected after transplantation indicate subclass switching during progression
of antibody-mediated rejection
Sait Sen
THE EFFECT OF HYPERCALCEMIA ON TUBULOINTERSTITIAL CALCIFICATION OF THE ALLOGRAFT
Tomokazu Shimizu
Clinical and pathological analyses of chronic vascular rejection after kidney transplantation
Yasemin Ozluk
Retrospective analysis of glomerulitis scoring by the last (Banff 2013) criteria: A single center observation
8
JOINT POSTERS & EXHIBITS: AUTHOR PRESENTATIONS (WED 6:30PM)
GRAND BALLROOM CD
An-Hang Yang
The association of microvascular remodeling and expression of mesenchymal phenotypes in renal allografts with
chronic active antibody-mediated rejection
Ana Konvalinka
Quantification of Angiotensin II Signature Proteins in Urine of Patients with Kidney Allograft
Berna Yelken
Are the characteristics of antibody mediated rejection predictive for the long term allograft survival?
Candice Roufosse
C4d positivity in renal biopsies without microcirculation inflammation or injury
Chia Wei Teoh
Mycophenolic acid levels are not associated with clinical adverse events at 3 months post-renal transplantation
Daniel Seron
Inflammation either associated or not with fibrosis at 6 week protocol biopsies is an independent predictor of 1
year DSA
Dima Kabbani
Vascular Jump Grafts in Liver Transplant: Do They Transmit Cytomegalovirus?
Harsharan Singh
Urinary Polyomavirus Haufen are Biomarkers for Polyomavirus Nephropathy: Mouse & Man & Proof of Concept
Holly Mansell
ELEVATED CIRCULATING INTERLEUKIN 33 LEVELS IN STABLE RENAL TRANSPLANT RECIPIENTS AT
HIGH RISK FOR CARDIOVASCULAR EVENTS
Karen Sherwood
TOWARDS CLINICAL NGS HLA-TYPING: A PERFORMANCE COMPARISON OF NEXT-GENERATION
SEQUENCING TECHNOLOGIES FOR DNA HLA TYPING IN A CLINICAL DIAGNOSTIC ENVIRONMENT
Maria Cristina Ribeiro de Castro
Microcirculation inflammation in early surveillance renal biopsy in sensitized patients did not correlate with graft
outcome.
Melanie Dieude
Tissue injury enhances circulating levels of active proteasome and triggers anti-LG3 production
Muhtashim Mian
Evaluation of a Novel Global Immunity Assay to Predict Clinical Outcomes in Organ Transplant Recipients
Natalie Montwill
Iron-dependent ferroptosis mediates microvascular endothelial cell survival following cardiac allograft
transplantation
Roslyn Mannon
The Missing Link in Kidney Allograft Loss: Renal Fibroblast Activation by Anti-Class I MHC Antibody
Sacha De Serres
Longitudinal Assessment of the Phenotype and Function of Monocytes in De Novo Kidney Transplant Recipients
Trana Hussaini
HCV Infection Interaction with Gender and Calcineurin Inhibitor Induced Chronic Renal Failure in Liver Transplant
Recipients: A Case-Control Study
Walter Park
120 Protocol Renal Allograft Biopsies at 10 Years Suggest New “Causes” of Chronic Injury
Yasemin Ozluk
Microcirculation inflammation and arteriolar hyalinosis predict graft loss in renal transplants without extensive
scarring
9
THURSDAY,OCTOBER8,2015
2015 STATUS REPORT ON ABMR (BREAKFAST PROVIDED WITH SUPPORT FROM ASTELLAS PHARMA INC.)
GRAND BALLROOM AB + PASSAGE (MODERATORS: ED KRAUS, CHRIS WIEBE)
Start
End
Description
Patricia Campbell
07:00
07:20
Epidemiology of ABMR
Mark Haas
07:20
07:40
Pathophysiology and Diagnostics of ABMR
Alex Loupy
07:40
08:00
Risk Stratification and Disease State Assessment in ABMR
POSTER SETUP
GRAND BALLROOM CD
Start
End
Description
07:00
09:30
Thursday Poster Boards – Poster Setup
ALLIED HEALTH GROUP – CANRESTORE MEETING
GULF ISLANDS BCD
Start
End
Description
08:00
10:00
External Meeting
JOINT PLENARY SESSION #2: FROM BASICS TO THERAPEUTICS IN ABMR
GRAND BALLROOM AB + PASSAGE (MODERATORS: HEINZ REGELE, PAUL KEOWN)
Start
End
Description
Stuart Knechtle
08:00
08:30
Improving Our Understanding of ABMR: What Are The Lessons From Non-Human Primate
Models?
Nicole Valenzuella
08:30
08:50
The Role of Macrophages in ABMR
Luis G. Hidalgo
08:50
09:10
Targeting ADCC and NK Cells in ABMR
David Rush
09:10
09:30
Clinical Relevance of Subclinical/Indolent Kidney Rejection Phenotypes
Coffee Break among Posters
Denis Glotz
10:00
10:20
What Are Our Surrogates for Treatment Efficacy in ABMR?
Stan Jordan
10:20
10:40
Complement Blockade in ABMR: Results and Perspectives
Robert Montgomery
10:40
11:00
Protocols for Preventing/Treating ABMR: Results and Perspectives
JOINT ORAL ABSTRACT PRESENTATIONS - SESSION II
GRAND BALLROOM AB + PASSAGE (MODERATORS: JAG GILL, MICHAEL MENGEL)
Start
End
Description
Jussi Tikkanen
11:00
11:10
De novo DQ-donor-specific antibodies are associated with chronic lung allograft dysfunction
after lung transplantation
Sarah Higgins
11:10
11:20
Identifying the specific causes and the determinants of outcome in kidney recipients with
Transplant Glomerulopathy: a multicenter study.
Caren Rose
11:20
11:30
Should the Kidney Donor Risk Index (KDRI) be used to quantify deceased donor quality in
Canada?
10
Babak Orandi
Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney
Transplantation
Marie Achille
11:40
11:50
The psychology and ethics of organ donation in the context of assisted suicide in Quebec.
Antoine Roux
11:50
12:00
Lung transplantation outcome is mainly driven by antibody mediated rejection
LUNCH SYMPOSIUM: MINIMIZATION, COMPLIANCE AND ABMR (LUNCH PROVIDED WITH SUPPORT FROM ASTELLAS
PHARMA INC.)
GRAND BALLROOM AB + PASSAGE (MODERATORS: DANIEL SERON, TOM BLYDT-HANSEN)
Start
End
Description
Chris Wiebe
12:00
12:20
De novo DSA: Prevalence, Pathophysiology and Allograft Injury
Beth Foster
12:20
12:40
Risk for ABMR in Adolescence: HLA-Matching, Recipient Age, and Compliance
Thomas Nevins
12:40
01:00
Predictive Patterns of Early Medication Adherence in Renal Transplantation
11:30
11:40
BANFF KIDNEY CONCURRENT II: DONOR SPECIFIC ANTI-HLA MEDIATED ALLOGRAFT INJURY AND BEYOND HLA
JUNIOR BALLROOM CD (MODERATORS: PATRICIA CAMPBELL, ALEX MAGIL)
Start
End
Description
Mark Haas
01:00
01:30
How Many ABMR Phenotypes Do Actually Exist? Consequences for Patient Care
Adriana Zeevi
01:30
02:00
Complement Binding Capacity of Anti HLA Antibodies: Multiorgan Clinical Relevance
Carmen Lefaucheur
02:00
02:30
Anti HLA DSA IgG Subclasses and Distinct Allograft Injury
Duska Dragun
02:30
03:00
Beyond HLA: Relevance of Other Targets
Coffee Break among Posters
Stuart Greenstein
04:30
05:00
Consensus Discussion #3: Definition of New Working Group: Clinico-Pathological
Consensus for the Assessment of Time Zero Donor Biopsies
BANFF VASCULARIZED COMPOSITE ALLOGRAFTS (VCA)
JUNIOR BALLROOM AB (MODERATORS: CINTHIA DRACHENBERG, ALTON FARRIS)
Start
End
Description
Linda Cendales
01:00
01:05
Welcome & Session Goals
Anil Chandraker
01:05
01:33
Histologic Features of Antibody Mediated Rejection after Face Transplantation
Jean Kanitakis
01:33
02:03
Graft Vasculopathy in the Skin After a Vascularized Composite Allograft
Adela Rambi Cardones
02:03
02:31
Skin in Transplantation
Gerald Brandacher
02:31
02:59
Expanding the Banff VCA Criteria
Coffee Break among Posters
03:30
05:00
Group Discussion
CANADIAN PANCREAS GROUP BUSINESS MEETING
ORCA
Start
End
Description
01:00
5:00
Closed Meeting (Members only)
11
CST PLENARY: ID
GRAND BALLROOM AB + PASSAGE (MODERATORS: ATUL HUMAR, ALISSA WRIGHT)
Start
End
Description
Nazia Selzner
01:00
01:30
New Therapies for HCV
Peter Stock
01:30
02:00
Transplanting the HIV+ Patient (and HIV+/HCV+), The HOPE Act
Glen Westall
02:00
02:30
Viral infection and Allograft Rejection in the Lung
Atul Humar
02:30
03:00
Viral Infection and the Allograft Rejection (Non-Lung)
Coffee Break among Posters
CST JOINT ETHICS & CRITICAL CARE SESSION: ISSUES IN DCD DONATION
GRAND BALLROOM AB + PASSAGE (MODERATORS: REBECCA GREENBERG, ADRIAN ROBERTSON)
Start
End
Description
Sonny Dhanani
03:30
03:55
Death Determination in Organ Donation
Robert Sibbald
03:55
04:20
Ethical Issues in DCD
Charlotte Harrison
04:20
04:45
Pediatric DCD and Lessons Learned from Debating and Implementing a DCD Policy in a
Pediatric Hospital
04:45
05:30
Panel Discussion
CST PHARMACIST GROUP BUSINESS MEETING & SESSION
FINBACK
Start
End
Description
Joseph Kim
03:30
04:15
Immunosuppressant Exposure Variability
David Taber
04:15
05:00
Medication Errors in Transplantation
Trana Hussaini
05:00
05:45
Re-thinking Immunosuppression in Liver Transplantation: A Focus on Minimization
05:45
06:00
Coffee Break
06:00
07:30
Pharmacist Group Business Meeting (Members only)
TTS WOMEN IN TRANSPLANTATION NETWORKING SESSION
PAVILLION BALLROOM CD
Start
End
Description
05:00
06:00
The Transplantation Society – WiTS Networking
POSTER DISMANTLE
GRAND BALLROOM CD
Start
End
Description
07:00
07:30
Thursday Poster Boards – Poster Dismantle
EXHIBIT HALL DISMANTLE
GRAND BALLROOM CD
Start
End
Description
07:00
011:00
Exhibition Dismantle
12
JOINT POSTERS & EXHIBITS: AUTHOR PRESENTATIONS (THURS 9:30AM)
GRAND BALLROOM CD
Alton Farris
NK Cell Activation Characterizes Chronic Antibody Mediated Rejection
Catriona Mckenzie
Oral nicotinamide to reduce nonmelanoma skin cancer in renal transplant recipients: a pilot Phase 2 randomized
controlled trial
Daniel Fantus
The impact of novel adenosine triphosphate-competitive inhibitors (TORKinibs) on alloimmunity and transplant
survival
G. V. Ramesh Prasad
Transplantation and the Nature of the Immune Self
Jessica Forcucci
Grading Capillaritis (ptc) in Renal Transplant Rejection: Can Ancillary Studies Improve Interobserver Variability
Karishma Kak
Patient Self-reported Adherence to and Perceptions towards Immunosuppressive Medications at the Outpatient
Renal Transplant Clinic
Kosuke Masutani
Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation in resolving polyomavirus
BK nephropathy
Luis G. Hidalgo
GENE EXPRESSION CHANGES IN NK CELLS FOLLOWING CD16 ACTIVATION - EVIDENCE FOR CD16
ENGAGEMENT IN BIOPSIES WITH ABMR
Luis G. Hidalgo
MOLECULAR ASSESSMENT OF THE COGNATE EVENTS IN T CELL- AND ANTIBODY-MEDIATED
REJECTION – TWO DIFFERENT CELLS WITH MANY KEY COMMON PROGRAMS
Meghan Kapp
Endothelial Activation and Lymphangiogenesis in Humoral Rejection of Kidney Transplants
Naima Carter-Monroe
DUAL LEUKOCYTE/ENDOTHELIAL STAIN FOR ASSESMENT OF ENDOCAPILLARY INFLAMMATION IN THE
RENAL ALLOGRAFT
Nithya Krishnan
CD45 Counts in Post Perfusion Biopsy Predicts AMR
Pallav Gupta
Acute and Chronic calcineurin inhibitor toxicity in live renal allograft recipients: clinical and histological features
Patrick Luke
First Canadian Experience with DCD Simultaneous Kidney Pancreas Transplantation
Ryan Rochon
Rhabdomyolysis after Hand Assisted Laparoscopic Donor Nephrectomy: Our Centre's Experience
Stephen Quigley
Acute Necrotizing Pancreatitis Following Living Kidney Donation - A Case Report and Systematic Review of the
Literature.
Thomas Brian McGregor
Right versus Left Laparoscopic Donor Nephrectomy : Initial 3 year Experience From a Single Centre Transplant
Program.
Xiu Qing (Jenny) Wang
Cell Type of the Tolerizing Inoculum Plays a Role in the Formation of Molecular Chimerism in Murine Neonatal
Tolerance
13
JOINT POSTERS & EXHIBITS: AUTHOR PRESENTATIONS (THURS 3PM)
GRAND BALLROOM CD
Benjamin Adam
The NanoString gene expression platform is technically robust and feasible for routine formalin-fixed paraffinembedded transplantation pathology applications
Carlos Cervera
Evaluation of qualitative and quantitative Epstein-Barr virus (EBV) DNA detection in whole blood at time of Posttransplant lymphoproliferative disorder (PTLD) diagnosis
Catherine Burton
Age of Clearance of Passive Maternal CMV IgG in Infants Awaiting Solid Organ Transplant
Christina Kaufman
Graft rejection in hand transplant recipients with grade 0 skin biopsy histology
Craig Hasilo
Inhibition of Neutrophil Migration Enhances Early Engraftment in a Nude Mouse Model of Human Islet
Transplantation
Dale Lien
Combined use of extended release and regular release tacrolimus in a child with cystic fibrosis and high
tacrolimus trough level variability post lung transplantation
Hongji Yang
Combination of Novel Anti-CD45RB and Anti-CD40 Chimeric Antibodies Promotes Operational Tolerance with a
Distinct Signature of Immunoregulatory Cells in Cynomolgus Monkey Renal Allograft Recipients
Hyeon Joo Jeong
Immunophenotype of Inflammatory Cells in Isolated V-Lesion of Allograft Kidney
Jee-Young Han
Clinico-pathologic characteristics of C4d negative antibody mediated rejection in renal allografts
Jorge Malheiro
GRAFT PATHOLOGY AND DONOR-SPECIFIC DE NOVO ALLOSENSITIZATION IN THE NATURAL HISTORY
OF KIDNEY TRANSPLANTATION: A CASE-CONTROL ANALYSIS
Julie Allard
PATIENTS’, CAREGIVERS’ AND RESEARCHERS’ PERSPECTIVES ON RESEARCH PRIORITIES IN ORGAN
TRANSPLANTATION IN CANADA.
Jutta Krista Preiksaitis
Residual risk of transfusion-acquired cytomegalovirus (CMV) infection in CMV seronegative solid organ transplant
recipients receiving CMV seronegative organs and leukoreduced cellular blood products
Olusegun Famure
MEDICAL AND NON-MEDICAL PREDICTORS OF COMPLETING THE TRANSPLANT EVALUATION PROCESS
IN END-STAGE RENAL DISEASE (ESRD) PATIENTS. – A SINGLE CENTRE STUDY
Roslyn Mannon
Understanding the Milieu of Brain Death: Donor Monocyte Chemoattractant Protein 1 (MCP-1) Predicts Recipient
Allograft Function
Sunita Singh
The Epidemiology of Pancreta Discard: An SRTR Analysis
Tariq Aljohani
EBV-positive lymphoid infiltrate in a renal surveillance biopsy mimicking subclinical T-cell mediated rejection
Virginie Royal
Eculizumab for the treatment of severe antibody-mediated rejection: a case report and review of the literature
14
JOINT POSTERS & EXHIBITS: AUTHOR PRESENTATIONS (THURS 6PM)
GRAND BALLROOM CD
Benjamin Adam
Internal and external validation of a molecular diagnostic for antibody-mediated rejection in routine formalin-fixed
paraffin-embedded renal allograft biopsies
Christina Dörje
Does total inflammation in early kidney graft biopsies predict progression of fibrosis and transplant function at 1
year post-transplant?
Dayanand Deo
Renal Histogenomics: Gene fingerprint to predict Delayed Graft Function
Elizabeth Martinez
Acute Vascular Lesions in the Kidney Transplant and Relationship to Cellular and Antibody-Mediated Rejection
(ABMR)
Erin Ready
Post-transplant lymphoproliferative disorder in adult kidney transplant patients: a British Columbia experience
G. V. Ramesh Prasad
TRANSPLANT TOURISM IS AN INDEPENDENT RISK FACTOR FOR LONG TERM KIDNEY ALLOGRAFT LOSS
Hanneke de Kort
Comparison of methods for assessment of peritubular capillary basement membrane multilayering (PTCBML)
Heounjeong Go
Refining the diagnostic criteria of transplant capillaropathy for chronic antibody-mediated rejection
Jan Ulrich Becker
Pathologists' individual approach to the diagnosis of Banff Borderline T-cell mediated rejection
Joseph Kim
Validation of Predictive Nomograms for Delayed Graft Function in Canadian Kidney Transplant Recipients
Julie Allard
Organ donation after cardiac death for a conscious patient: new ethical issues
Li-Zzu Lin
Primary hepatic angiosarcoma treated with living dornor liver transplantation
Marie Wright
Long-term respiratory morbidity in recipients of pediatric solid organ transplants: a retrospective review.
Rajan Duggal
Clinicopathologic spectrum of plasma cell–rich acute rejection: An aggressive morphologic form of acute rejection
Ruth Sapir-Pichhadze
Kidney Transplant Outcomes following Alemtuzumab Induction and a Steroid-Free Protocol vs. rATG Induction
and Maintenance Steroids
Seyed M Hosseini-Moghaddam
Antiviral Prophylaxis against Early-Onset Post-Transplant Lymphoproliferative Disease in Epstein-Barr Virus
Seronegative Renal Transplants, Single Arm Cohort Study
Shaifali Sandal
Renal Resistance Measured during Pulsatile Perfusion and Long-Term Kidney Transplant Outcomes
Szu-Han Wang
Predictors of biliary leakage after T-tube removal in living donor liver transplantation recipients
15
JOINT POSTERS & EXHIBITS: AUTHOR PRESENTATIONS (THURS 6:30PM)
GRAND BALLROOM CD
Alberto González-Almada
Histologic Findings in Pre-transplant AT1Rab + ve Patients: Increase in Sub-intimal Fibrosis During Acute
Rejection and in 12 mo. Protocol Renal Graft Biopsies.
C Deblais
DIFFUSE, INTENSE, LINEAR (DIL) C4d GLOMERULAR CAPILLARY POSITIVITY IS A STRONG MARKER FOR
THE DIAGNOSIS OF CHRONIC ANTIBODY MEDIATED REJECTION.
Erik Larsson
Systematic morphological evaluation of consecutive protocol biopsies of the duodenal cuff in clinical pancreas
transplantation
Farsad-Alexander Eskandary
The prevalence of late HLA-DSA-positive antibody-mediated rejection in kidney transplant recipients and the
diagnostic value of antibody properties: Results of a large prospective cross-sectional study
Istvan Mucsi
Mental health and behavioral barriers to completing the pre-transplant evaluation
Istvan Mucsi
African Canadian and Asian Canadian patients are less likely to have potential living donors when first presenting
for evaluation: A single center experience
James Lan
Clinical Relevance of Complement-Activating Donor-Specific Antibodies Identified by a Novel C3d Assay in
Predicting Kidney Allograft Failure
Johan Molne
Rejection patterns and a grading system for cervical biopsies after human uterus transplantation
Joseph Kahwaji
Pathological Finidngs in HLA Sensitized Patients Treated with Everolimus: Interim Results
Joseph Kim
Incidence, Risk Factors, and Clinical Outcomes of BK Virema in the Modern Era of Kidney Transplantation
Kyla Naylor
Frequency of Bone Mineral Density Testing in Adult Kidney Transplant Recipients
Marie-Chantal Fortin
Patients’ Perspectives on Cardiovascular Risk Factors after Kidney Transplantation
Michael Moser
Early experience with machine cold perfusion of living donor kidneys
Nada Alachkar
IgA nephropathy recurrence after kidney transplantation
Ngan Lam
Gender Differences in Use of Prescription Narcotic Medications among Living Kidney Donors
Rhea Varughese
A Single Centre’s Lung Transplantation Experience for Pulmonary Graft versus Host Disease
Shigeo Hara
Granular swollen epithelial cells in the kidney allograft: a marker for kidney allograft senescence?
Sunita Singh
External Validation of Clinical Prediction Models of Patient and Graft Survival in a Canadian Cohort of Kidney
Transplant Recipients
16
FRIDAY,OCTOBER9,2015
PUBLIC SOLICITATION AND DIRECTED ANONYMOUS DONATION SYMPOSIUM
GRAND BALLROOM AB + PASSAGE (MODERATOR: STEVEN PARASKEVAS)
Start
End
Description
07:00
08:00
Breakfast Symposium
BANFF SUMMARY
PAVILLION BALLROOM D
Start
End
Description
08:00
12:00
Banff Summary
CST LIVER CONCURRENT SESSION
JUNIOR BALLROOM B (MODERATORS: IAN ALWAYN, MARKUS SELZNER)
Start
End
Description
08:00
09:00
Sandy Feng
Liver Transplantation for HCC-Milan, UCSF, TTV: Where do we go?
09:00
09:15
Karen Pineda-Solis
“Functional” Warm Ischemia Time as a Predictor of Graft Failure and Biliary Complications.
09:15
09:30
Juan Echeverri
Subnormothermic Ex-Vivo Liver Perfusion (SNEVLP) Reduces Endothelial Cell Damage and
Bile Duct Injury after Pig Liver Transplantation with HBD Grafts
09:30
09:45
David Forner
Donor Specific Antibodies in Liver Transplantation: Do Complement Fixing Antibodies Predict
Outcomes?
09:45
10:00
Ahmed Alqallaf
Correlation of Serum Creatinine-Based Equations With Radionuclide GFR in Candidates for
Liver Transplantation
10:30
10:45
Nazia Selzner
Debate: Is six months abstinence required for liver transplantation in patients with alcohol
induced liver disease? PROS
10:45
11:00
James Shapiro
Debate: Is six months abstinence required for liver transplantation in patients with alcohol
induced liver disease? CONS
11:00
11:15
Juan Echeverri
Live Donor Liver Transplantation with Older (>50years) vs Younger (<50years) Donors: Does
Age Matter?
11:15
11:30
Trana Hussaini
Immunosuppression practices in liver transplantation: A survey of North American Centres
11:30
11:45
Juan Echeverri
Fast Track of Adult-to-Adult Live Donor Liver Transplant Recipients: Avoiding ICU Admission
Reduces Complications and Post Transplant Hospital Stay
11:45
12:00
Ibrahim Al Hasan
The Fate of the DCD Liver Follows the Kidney
CST LUNG CONCURRENT SESSION
JUNIOR BALLROOM A (MODERATOR: LIANNE SINGER)
Start
End
Description
08:00
08:45
Glen Westall
Making Sense of Antibodies before and after Lung Transplantation
08:45
09:30
Jussi Tikkanen
Antibodies in Lung Transplantation - What do we know and what can we do?
09:30
09:40
Alim Hirji
Clinical Judgment Versus Lung Allocation Score in Predicting Waitlist Mortality
09:40
09:50
Nader Aboelnazar
The Value of Hypoxic Pulmonary Vasoconstriction in Determining Lung Health During ExVivo Lung Perfusion
17
09:50
10:00
Katie Kinaschuk
Evolving strategies for Mechanical Circulatory Support in Bridging prior to Lung
Transplantation
10:30
10:40
Sunita Mathur
Persistent Skeletal Muscle Weakness And Atrophy After Lung Transplantation
10:40
10:50
Dale Lien
Donor Specific Antibody (DSA) Associated With Significant Bilateral Upper Lobe Pleural
Thickening And Lung Graft Dysfunction
CST-CSN JOINT KIDNEY-PANCREAS CONCURRENT SESSION
PAVILLION BALLROOM C (MODERATORS: RAMESH PRASAD, JAG GILL)
Start
End
Description
08:00
08:40
Hatem Amer
Treasure in the Waste-Post Transplant Proteinuria
08:40
09:20
G. V. Ramesh Prasad
Metabolic Syndrome, Chronic Kidney Disease, and Transplantation
09:20
10:00
Greg Knoll
Post-Transplant Malignancy
10:30
10:40
Cecilia Kwok
Caspase-8 has paradoxical function in ischemia-reperfusion injury versus transplantation due
to differences in intracellular pH
10:40
10:50
Melanie Dieude
The 20S proteasome activity within apoptotic nanovesicles controls immune responses to the
allograft
10:50
11:00
Ryan Cunnington
Epithelial-to-Mesenchymal transition as a mechanism for BK virus induced kidney fibrosis
11:00
11:10
Kevin Wen
IgA Nephropathy: HLA Class II zero mismatch living donor kidney transplantation associated
with increased recurrence and graft loss
11:10
11:20
Sunita Singh
Is Delayed Graft Function in Simultaneous Kidney-Pancreas Transplant Recipients
Associated with an Increased Risk of Pancreas Graft Failure?
11:20
11:30
Olusegun Famure
Neighbourhood-level socioeconomic predictors for completing the assessment and
progressing to kidney transplant among referred end-stage renal disease patients
11:30
11:40
Ye Su
Loss of RIPK3 and Caspase-8 Enhance Intrinsic Apoptosis in Tubular Epithelial Cell (TEC)
Death and Contributes to Kidney Ischemia Reperfusion Injury (IRI)
11:40
11:50
Michael Moser
Protection of the transplant kidney from preservation injury by inhibition of matrix
metalloproteinases
11:50
12:00
Tom Blydt-Hansen
Urine metabolites as biomarkers for kidney antibody-mediated rejection
12:00
12:10
Gaurav Tripathi
Genetic Predisposition to Interleukin-10 production influences Epstein–Barr Virus
Reactivation after Renal Transplantation
CST DONATION CONCURRENT SESSION
PAVILLION AB (MODERATOR: ADRIAN ROBERTSON)
Start
End
Description
08:30
09:15
Adrian Robertson
Space and Time of Discussions with Donor Families.
09:15
10:00
Sonny Dhanani
Donation Physician Specialists
10:30
11:00
Robert Sibbald
Consent to Donation is Trickier Than it Looks
18
11:00
11:10
Michael Moser
What messages are potential donor families receiving from the Internet about Donation after
Cardiac Death?
11:10
11:20
Daniel Buchman
Organ Donation after Physician Assisted Death in Canada: Ethical and Legal Issues
11:20
11:30
Elizabeth Hendren
Where should the public learn about organ donation: Health Care Settings or the DMV?
11:30
11:40
Samantha Anthony
Family Veto in Organ Donation
11:40
11:50
Caren Rose
The number of HIV-infected potential deceased organ donors in Canada
11:50
12:00
Maeghan Toews
Family Override of Consent for Organ Donation: The Disconnect between Law and Policy
12:00
12:10
Sonny Dhanani
Increase In Neurologic Determination Of Death (NDD) Organ Donation In The Donation After
Cardiac Death (DCD) Era. The Ontario Experience.
CST HEART CONCURRENT SESSION
JUNIOR BALLROOM C (MODERATORS: LORI WEST, BRUCE MCMANUS)
Start
End
Description
09:00
09:30
Bruce McManus
Biomarkers for Monitoring Cardiac Allograft Rejection: Ready for Prime Time?
09:30
10:00
Michael Mengel
Antibody Mediated Rejection in Heart Transplantation: What Is The Diagnostic Gold
Standard in 2015?
10:30
10:42
Xusheng Zhang
Prolongation of Cardiac Allograft Survival through Targeted Silencing of TLR Adaptor Genes
using Mannose Liposome
10:42
10:54
Medhat Askar
Association of Complement Activation Product C5a with Allosensitization in Patients with
Ventricular Assist Devices
10:54
11:06
Ye Su
Intracellular OPN is an essential protective factor to cardiac endothelial cell and the long term
heart graft survival
11:06
11:18
Stanley Araujo
Reactivation Chagoma in Heart Transplanted patients
11:18
11:30
Mark Kearns
Donor Death and Cardiac Injury After Withdrawal of Life Support in a Rodent DCD Protocol
11:30
11:42
Bruce Motyka
Tolerance to A-Antigen Following ABO-Incompatible Heart Transplantation (HTx) in a Blood
Group A-Transgenic Mouse Model
11:42
11:54
Cecilia Kwok
CD4+ T-cell mediated microvascular endothelial cell death in a chronic cardiac allograft
rejection model involves RIPK3
11:54
12:06
Romy Hoeppli
Tailoring Homing Capacity of Thymic Regulatory T Cells by Expansion in Cytokine-enriched
Culture Conditions
CST RESEARCH COMMITTEE MEETING
GULF ISLANDS BCD
Start
End
Description
12:30
01:30
External Meeting
CNTRP SESSION
GRAND BALLROOM AB + PASSAGE
Start
End
Description
01:00
02:00
Canadian National Transplant Research Program Session
19
CST FELLOWSHIP PRESENTATION
GRAND BALLROOM AB + PASSAGE (MODERATOR: RAMESH PRASAD)
Start
End
Description
02:00
02:15
Esme Dijke
Transplantation in infancy: exploring pathways to tolerance induction
PANEL ON QUALITY IN TRANSPLANTATION
GRAND BALLROOM AB + PASSAGE (MODERATORS: PROSANTO CHAUDHURY, JOHN GILL)
Start
End
Description
02:30
02:50
Greg Knoll
An introduction to Quality. What is Quality? How does one measure it?
02:50
03:10
Dorry Segev
What is being done in the US? Program specific reporting (PSR) and how it works.
03:10
03:30
Stuart Greenstein
TransQIP and beyond
03:30
04:00
Panel Discussion
04:00
04:15
Coffee Break
CST ANNUAL GENERAL MEETING
GRAND BALLROOM AB + PASSAGE
Start
End
Description
04:15
05:45
Closed Meeting (Members only)
CST BOARD MEETING
GULF ISLANDS BCD
Start
End
Description
06:00
06:30
Closed Meeting (Members only)
CONFERENCE DINNER & AWARDS GALA
PAVILLION BALLROOM CD
Start
End
Description
07:30
10:00
Ticketed Social Event
SATURDAY,OCTOBER10,2015
CST LUNG GROUP BUSINESS MEETING
PORT ALBERNI
Start
End
Description
09:00
12:00
Closed Meeting (Members only)
20